Kaitlyn Kosko

Kaitlyn Kosko

Articles by Kaitlyn Kosko

Kaitlyn KoskoSmall Cell Lung Cancer | April 19, 2024
The timing of chemotherapy given to patients with SCLC does not have a statistically significant impact on OS.
Kaitlyn KoskoSmall Cell Lung Cancer | April 18, 2024
The timing of chemotherapy given to patients with SCLC does not have a statistically significant effect on OS.
Kaitlyn KoskoLung Cancer | April 18, 2024
Lung cancer screening discussions are not happening as often as they could be among health care providers.
Kaitlyn KoskoLung Cancer | April 18, 2024
The postoperative comfort scale has good reliability and validity, and can be used to assess patients with lung cancer.
Kaitlyn KoskoNon-Small Cell Lung Cancer | April 17, 2024
Preoperative ctDNA has prognostic value for determining long-term prognosis for NSCLC.
Kaitlyn KoskoNon-Small Cell Lung Cancer | April 17, 2024
Clinical trial investigators should use a mindful approach when planning to assess HRQOL in NSCLC.
Kaitlyn KoskoNon-Small Cell Lung Cancer | April 17, 2024
It is reasonable to upgrade ECE of tumor in lymph nodes from R0 to incomplete resection.
Kaitlyn KoskoNon-Small Cell Lung Cancer | April 17, 2024
Worse clinical outcomes and higher risk for brain metastasis are more likely to happen in patients with metastatic NSCLC.
Kaitlyn KoskoMesothelioma | April 17, 2024
Occupational asbestos exposure leads to shorter survival in patients with malignant mesothelioma.
Kaitlyn KoskoMesothelioma | April 17, 2024
Guideline-concordant therapy remains underused in most mesothelioma patients.
Kaitlyn KoskoLung Cancer | March 28, 2024
Opportunistic screening for lung cancer helped lower the risk of death related to the disease in China.
Kaitlyn KoskoLung Cancer | March 28, 2024
Low-dose computed tomography can reduce the number of deaths from lung cancer in Brazil.
Kaitlyn KoskoNon-Small Cell Lung Cancer | March 28, 2024
The use of tobacco negatively affects survival outcomes in patients with advanced NSCLC.
Kaitlyn KoskoNon-Small Cell Lung Cancer | March 28, 2024
Patients with EGFR-positive metastatic NSCLC whose disease progressed following first-line treatment have worse outcomes.
Kaitlyn KoskoNon-Small Cell Lung Cancer | March 28, 2024
Patient selection for perioperative immunotherapies may be determined by specific intratumoral immune cells.
Kaitlyn KoskoMesothelioma | March 22, 2024
A complete residential history should be reviewed following a mesothelioma diagnosis.
Kaitlyn KoskoLung Cancer | March 22, 2024
Patients with lung cancer who were treated with ICIs and developed TRL had poorer survival outcomes.
Kaitlyn KoskoLung Cancer | March 22, 2024
Individuals with poor sleep quality are more likely to get lung cancer than those with good sleep quality.
Kaitlyn KoskoNon-Small Cell Lung Cancer | March 21, 2024
Researchers created a novel prediction model that can forecast OS in patients with adenocarcinoma.
Kaitlyn KoskoLung Cancer | February 27, 2024
After an IPPC, the incidence of second primary lung cancer is high among never-smokers.